Evidence map›Paper›PMID 35147763›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2022

Plasma lipidomics analysis reveals altered lipids signature in patients with osteonecrosis of the femoral head.

Yuzhu Yan, Jihan Wang, Dageng Huang, Jing Lv, Hui Li, Jing An, Xiaojian Cui, Heping Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuzhu Yan *Clinical Laboratory of Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.ORCID 0000-0001-6496-1706
Jihan Wang *Institute of Medical Research, Northwestern Polytechnical University, Xi'an, 710072, China.
Dageng HuangDepartment of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Jing LvClinical Laboratory of Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Hui LiDepartment of Joint Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Jing AnTranslational Medicine Center, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Xiaojian CuiDepartment of Radiology, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Heping ZhaoClinical Laboratory of Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China. redcrossjyk@163.com.
Xi'an Honghui Hospital · CNNorthwestern Polytechnical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough studies have established a link between lipid metabolism disorder and osteonecrosis of the femoral head (ONFH), the characteristics of the circulating lipidome signature of ONFH have not yet been investigated and need to be explored.

objectivesWe aimed to explore the plasma lipidome signatures in patients with ONFH, and to identify specific lipid biomarkers of ONFH.

methodsIn this study, a comprehensive detection and analysis of plasma lipidomics was conducted in clinical human cohort, including 32 healthy normal control (NC) subjects and 91 ONFH patients in different subgroups [alcohol-induced ONFH (AONFH), steroid-induced ONFH (SONFH), and traumatic-induced ONFH (TONFH)] or at different disease stages (stage I, II, III and IV of ONFH) using ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS).

resultsOverall, the plasma lipidome profile differs between ONFH and NC samples. Lipidome signature including 22 common differentially expressed lipids (DELs) in all three subgroups (variable importance in projection > 1, P < 0.05, fold change > 1.5 or < 0.67, compared to the NC group) was identified. Besides, the subtype-specific lipidome profiles for each ONFH subgroup were also analyzed. Generally, the AONFH subgroup has the largest number of DELs, and the plasma levels of triacylglycerol lipid compounds increased obviously in the AONFH samples. In the subgroup of SONFH, the relative abundance of lipid 4-Aminobenzoic acid increased significantly with changes in the expression of several of its interactive genes. We have identified that 9 stage-positive and 2 stage-negative lipids may function as novel biomarkers predicting the progression of ONFH.

conclusionOur study presents an overview of the phenotype-related plasma lipidome signature of patients with ONFH. The results will provide insight into the mechanisms underlying the metabolism of lipids in the pathogenesis and progression of ONFH and help identify novel lipids biomarkers or disease diagnosis and treatment targets.

Indexed as

LipidomicsOsteonecrosisFemur HeadHumansMetabolomicsTandem Mass SpectrometryTriglyceridesTriglyceridesChemical-gene interactionLipid biomarkerLipidomicsMass spectrometryOsteonecrosis of the femoral head

Identifiers

PMID35147763
OpenAlexW4211117435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.